BofA Securities Starts Amphastar Pharmaceuticals (AMPH) at Neutral
Tweet
Share
E-mailGet Alerts AMPH Hot Sheet
Price: $20.12 -0.3%
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
BofA Securities analyst Jason Gerberry initiates coverage on Amphastar Pharmaceuticals (NASDAQ: AMPH) with a Neutral rating and a price target of $63.00.
For an analyst ratings summary and ratings history on Amphastar Pharmaceuticals click here. For more ratings news on Amphastar Pharmaceuticals click here.
Shares of Amphastar Pharmaceuticals closed at $56.17 yesterday.
You May Also Be Interested In
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- Alliance Global Partners Starts Momentus (MNTS) at Buy
- Canaccord Starts Kazia Therapeutics (KZIA) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
